CDIO Cardio Diagnostics Holdings, Inc.
USHealthcareAs of 2026-07-10 14:43
Why CDIO matters now
Cardio Diagnostics Holdings, Inc. (CDIO) is a US stock in Healthcare. The latest InvestLog snapshot shows $1.84 with -0.54% on the session and $3.8M in market capitalization; recent performance reads 1-month +44.53% and YTD -26.94%.
The latest financial table shown here is Q1 2026, with revenue of $2.7K, net income of $-1.8M, and EPS of $-0.63. Investors can compare that operating picture with valuation signals such as P/E unavailable and FCF yield -148.5%.
The latest indexable market news headline is "Atlas Healthcare Physicians to Cover Cardio Diagnostics' Precision Cardiovascular Medicine Tests Across Its Network" from Business Wire.
Additional event context on this page matters because analyst consensus is Buy with a median target of $—; recent insider activity includes Burton Paul Frederick filing A-Award. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
—
PEG
—
P/B
0.63
P/S
247.50
EV/EBITDA
0.39
DCF Value
$2.23
FCF Yield
-148.5%
Div Yield
0.0%
Margins & Returns
Gross Margin
-471.4%
Operating Margin
-40074.6%
Net Margin
-40152.5%
ROE
-78.8%
ROA
-69.6%
ROIC
-70.3%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.7K | $-1.8M | $-0.63 |
| Q4 2025 | $3.6K | $-1.5M | $-0.80 |
| FY 2025 | $14.8K | $-6.5M | $-3.71 |
| Q3 2025 | $2.9K | $-1.7M | $-0.98 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$—
Target (Median)
$—
Target Range
$— - $—
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Biotechnology
Country
US
Exchange
—
Beta
2.20
Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.